DJIA 16,386.12 123.56 0.76%
NASDAQ 4,067.27 33.11 0.82%
S&P 500 1,853.73 10.75 0.58%
market minute promo

1.49 -0.07 (-4.19%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

LXRX $1.49 -4.19%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.56
Previous Close $1.55
Daily Range $1.47 - $1.57
52-Week Range $1.39 - $3.18
Market Cap $763.0M
P/E Ratio -7.75
Dividend (Yield) $0.00 (0.0%)
Volume 721,630
Average Daily Volume 1,552,876
Current FY EPS -$0.16

Sector

Healthcare

Industry

Drugs

Lexicon Pharmaceuticals, Inc. (LXRX) Description

A biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease. Website: http://www.lexicon-genetics.com/

News & Commentary

Lexicon Pharma to Cut Around 45% of Workforce; CEO to Depart

Lexicon Pharmaceuticals will focus its efforts on late-stage drug development, which will lead to the loss of 115 jobs.

Encouraging Results from Lexicon Candidate - Analyst Blog

More Positive News For Lexicon, But Not The Big Announcement

Lexicon Pharmaceuticals' CEO Discusses LX4211 Positive Results in Type 1 Diabetes Clinical Trial (Tr

Lexicon Pharmaceuticals' CEO Discusses LX4211 Positive Results in Type 1 Diabetes Clinical Trial (Transcript)

Mid-Morning Market Update: Markets Open Higher; Citigroup Results Beat Estimates

Mid-Morning Market Update: Markets Open Higher; Citigroup Results Beat Estimates

Morning Market Movers

Sector Update: Healthcares Flat to Lower Pre-Market; Lexicon Soars 20% on Study of Diabetes Treatmen

Sector Update: Healthcares Flat to Lower Pre-Market; Lexicon Soars 20% on Study of Diabetes Treatment

Lexicon Pharmaceuticals up 25% on drug trial

Lexicon Pharmaceuticals' CEO Discusses Q4 2013 Results - Earnings Call Transcript

5 Stocks Under $10 Set to Soar

See More LXRX News...

LXRX's Top Competitors

LXRX $1.49 (-4.19%)
Current stock: LXRX
AMGN $114.56 (-0.38%)
Current stock: AMGN
GILD $68.85 (1.00%)
Current stock: GILD
BIIB $290.56 (1.78%)
Current stock: BIIB